{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T08:28:25Z","timestamp":1793780905700,"version":"4.6.1"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"2","funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2,1]]},"DOI":"10.1093\/jnci\/djy084","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T15:11:28Z","timestamp":1522854688000},"page":"129-136","source":"Crossref","is-referenced-by-count":91,"title":["Antibodies Against <i>Chlamydia trachomatis<\/i> and Ovarian Cancer Risk in Two Independent Populations"],"prefix":"10.1093","volume":"111","author":[{"given":"Britton","family":"Trabert","sequence":"first","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Waterboer","sequence":"additional","affiliation":[{"name":"Infections and Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Idahl","sequence":"additional","affiliation":[{"name":"Department of Clinical Science, Obstetrics and Gynecology, Ume\u00e5 University, Ume\u00e5, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Brenner","sequence":"additional","affiliation":[{"name":"Infections and Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise A","family":"Brinton","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Butt","sequence":"additional","affiliation":[{"name":"Infections and Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally B","family":"Coburn","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Hartge","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Hufnagel","sequence":"additional","affiliation":[{"name":"Infections and Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Inturrisi","sequence":"additional","affiliation":[{"name":"Infections and Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta","family":"Lissowska","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Cancer Prevention, Cancer Center and M. Sklodowska-Curie Institute of Oncology, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Mentzer","sequence":"additional","affiliation":[{"name":"Wellcome Centre for Human Genetics, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"Peplonska","sequence":"additional","affiliation":[{"name":"Department of Environmental Epidemiology, Nofer Institute of Occupational Medicine, Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E","family":"Sherman","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, Mayo Clinic, Jacksonville, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian S","family":"Wills","sequence":"additional","affiliation":[{"name":"Jefferiss Research Trust Laboratories, Imperial College London, St Mary\u2019s Campus, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah C","family":"Woodhall","sequence":"additional","affiliation":[{"name":"National Infection Service, Public Health England, London, UK"},{"name":"Research Department of Infection and Population Health, UCL, London, UK"},{"name":"Gloucestershire Hospitals NHS Foundation Trust, Cheltenham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Pawlita","sequence":"additional","affiliation":[{"name":"Molecular Diagnostics of Oncogenic Infections Division, German Cancer Research Center (DKFZ), Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Wentzensen","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,5,21]]},"reference":[{"key":"key\n\t\t\t\t2019021509101350800_djy084-B1","volume-title":"Cancer Facts & Figures.","author":"American Cancer Society","year":"2017","edition":"2017"},{"issue":"4","key":"key\n\t\t\t\t2019021509101350800_djy084-B2","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/path.1000","article-title":"Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer","volume":"195","author":"Piek","year":"2001","journal-title":"J Pathol."},{"issue":"7","key":"key\n\t\t\t\t2019021509101350800_djy084-B3","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.humpath.2011.03.003","article-title":"Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer\u2014shifting the paradigm","volume":"42","author":"Kurman","year":"2011","journal-title":"Hum Pathol."},{"key":"key\n\t\t\t\t2019021509101350800_djy084-B4","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1097\/IGC.0b013e31824d7269","article-title":"BRCA, the Oviduct, and the space and time continuum of pelvic serous carcinogenesis","volume":"22","author":"Crum","year":"2012","journal-title":"Int J Gynecol Cancer."},{"key":"key\n\t\t\t\t2019021509101350800_djy084-B5","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/annonc\/mdt308","article-title":"Coming into focus: The nonovarian origins of ovarian cancer","volume":"24","author":"Dubeau","year":"2013","journal-title":"Ann Oncol."},{"issue":"9","key":"key\n\t\t\t\t2019021509101350800_djy084-B6","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/aje\/kwv308","article-title":"Lifetime number of ovulatory cycles and risks of ovarian and endometrial cancer among postmenopausal women","volume":"183","author":"Yang","year":"2016","journal-title":"Am J Epidemiol."},{"issue":"17","key":"key\n\t\t\t\t2019021509101350800_djy084-B7","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1093\/jnci\/91.17.1459","article-title":"Possible role of ovarian epithelial inflammation in ovarian cancer","volume":"91","author":"Ness","year":"1999","journal-title":"J Natl Cancer Inst."},{"issue":"24","key":"key\n\t\t\t\t2019021509101350800_djy084-B8","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1200\/JCO.2016.66.8178","article-title":"Ovarian cancer risk factors by histologic subtype: An analysis from the Ovarian Cancer Cohort Consortium","volume":"34","author":"Wentzensen","year":"2016","journal-title":"J Clin Oncol."},{"issue":"4","key":"key\n\t\t\t\t2019021509101350800_djy084-B9","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/01.ede.0000164812.02181.d5","article-title":"Causes of infertility as predictors of subsequent cancer risk","volume":"16","author":"Brinton","year":"2005","journal-title":"Epidemiology."},{"key":"key\n\t\t\t\t2019021509101350800_djy084-B10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13027-017-0134-9","article-title":"The potential role of infectious agents and pelvic inflammatory disease in ovarian carcinogenesis","volume":"12","author":"Ingerslev","year":"2017","journal-title":"Infect Agent Cancer."},{"issue":"9","key":"key\n\t\t\t\t2019021509101350800_djy084-B11","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/S1470-2045(11)70165-6","article-title":"Risk of ovarian cancer in women with pelvic inflammatory disease: A population-based study","volume":"12","author":"Lin","year":"2011","journal-title":"Lancet Oncol."},{"issue":"5","key":"key\n\t\t\t\t2019021509101350800_djy084-B12","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s10552-017-0873-3","article-title":"Pelvic inflammatory disease and the risk of ovarian cancer: A meta-analysis","volume":"28","author":"Zhou","year":"2017","journal-title":"Cancer Causes Control."},{"issue":"5","key":"key\n\t\t\t\t2019021509101350800_djy084-B13","first-page":"447","article-title":"Pelvic inflammatory disease and the risk of epithelial ovarian cancer","volume":"4","author":"Risch","year":"1995","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"issue":"10","key":"key\n\t\t\t\t2019021509101350800_djy084-B14","article-title":"Current gaps in ovarian cancer epidemiology: The need for new population-based research","volume":"109","author":"Epidemiology Working Group Steering Committee","year":"2017","journal-title":"J Natl Cancer Inst."},{"issue":"4","key":"key\n\t\t\t\t2019021509101350800_djy084-B15","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.idc.2013.08.004","article-title":"Pelvic inflammatory disease: Current concepts in pathogenesis, diagnosis and treatment","volume":"27","author":"Mitchell","year":"2013","journal-title":"Infect Dis Clin North Am."},{"issue":"7","key":"key\n\t\t\t\t2019021509101350800_djy084-B16","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1086\/368380","article-title":"Serologic evidence of past infection with Chlamydia trachomatis, in relation to ovarian cancer","volume":"187","author":"Ness","year":"2003","journal-title":"J Infect Dis."},{"key":"key\n\t\t\t\t2019021509101350800_djy084-B17","doi-asserted-by":"crossref","first-page":"824627","DOI":"10.1155\/2011\/824627","article-title":"Chlamydia trachomatis and Mycoplasma genitalium plasma antibodies in relation to epithelial ovarian tumors","volume":"2011","author":"Idahl","year":"2011","journal-title":"Infect Dis Obstet Gynecol."},{"key":"key\n\t\t\t\t2019021509101350800_djy084-B18","doi-asserted-by":"crossref","first-page":"219672","DOI":"10.1155\/2008\/219672","article-title":"Chlamydia trachomatis serology in women with and without ovarian cancer","volume":"2008","author":"Ness","year":"2008","journal-title":"Infect Dis Obstet Gynecol."},{"key":"key\n\t\t\t\t2019021509101350800_djy084-B19","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1471-2407-7-60","article-title":"Ovarian cancer risk and common variation in the sex hormone-binding globulin gene: A population-based case\u2013control study","volume":"7","author":"Garcia-Closas","year":"2007","journal-title":"BMC Cancer."},{"issue":"6 Suppl","key":"key\n\t\t\t\t2019021509101350800_djy084-B20","doi-asserted-by":"crossref","first-page":"273S","DOI":"10.1016\/S0197-2456(00)00098-2","article-title":"Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial","volume":"21","author":"Prorok","year":"2000","journal-title":"Control Clin Trials."},{"issue":"2","key":"key\n\t\t\t\t2019021509101350800_djy084-B21","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ygyno.2014.08.025","article-title":"Pre-diagnostic serum levels of inflammation markers and risk of ovarian cancer in the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial","volume":"135","author":"Trabert","year":"2014","journal-title":"Gynecol Oncol."},{"issue":"1\u20132","key":"key\n\t\t\t\t2019021509101350800_djy084-B22","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.mrfmmm.2005.06.013","article-title":"Methods for etiologic and early marker investigations in the PLCO trial","volume":"592","author":"Hayes","year":"2005","journal-title":"Mutat Res."},{"issue":"3","key":"key\n\t\t\t\t2019021509101350800_djy084-B23","doi-asserted-by":"crossref","first-page":"e0151497","DOI":"10.1371\/journal.pone.0151497","article-title":"Chlamydia trachomatis Pgp3 antibody persists and correlates with self-reported infection and behavioural risks in a blinded cohort study","volume":"11","author":"Horner","year":"2016","journal-title":"PLoS One."},{"key":"key\n\t\t\t\t2019021509101350800_djy084-B24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jim.2017.03.002","article-title":"Development and evaluation of an enzyme-linked immunosorbent assay for the detection of antibodies to a common urogenital derivative of Chlamydia trachomatis plasmid-encoded PGP3","volume":"445","author":"Winstanley","year":"2017","journal-title":"J Immunol Methods."},{"issue":"6","key":"key\n\t\t\t\t2019021509101350800_djy084-B25","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.2105\/AJPH.2005.074062","article-title":"Mycoplasma genitalium among young adults in the United States: An emerging sexually transmitted infection","volume":"97","author":"Manhart","year":"2007","journal-title":"Am J Public Health."},{"issue":"8","key":"key\n\t\t\t\t2019021509101350800_djy084-B26","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/sextrans-2015-052011","article-title":"Mycoplasma genitalium serum antibodies in infertile couples and fertile women","volume":"91","author":"Idahl","year":"2015","journal-title":"Sex Transm Infect."},{"issue":"12","key":"key\n\t\t\t\t2019021509101350800_djy084-B27","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/01.olq.0000218869.52753.c7","article-title":"The associations between pelvic inflammatory disease, Trichomonas vaginalis infection, and positive herpes simplex virus type 2 serology","volume":"33","author":"Cherpes","year":"2006","journal-title":"Sex Transm Dis."},{"issue":"10","key":"key\n\t\t\t\t2019021509101350800_djy084-B28","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1373\/clinchem.2005.052381","article-title":"Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins","volume":"51","author":"Waterboer","year":"2005","journal-title":"Clin Chem."},{"issue":"9","key":"key\n\t\t\t\t2019021509101350800_djy084-B29","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1158\/1055-9965.EPI-15-0351","article-title":"Hepatitis C virus seroprevalence in mongolian women assessed by a novel multiplex antibody detection assay","volume":"24","author":"Dondog","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"issue":"1","key":"key\n\t\t\t\t2019021509101350800_djy084-B30","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/aje\/kwv155","article-title":"Seroepidemiology of human polyomaviruses in a US population","volume":"183","author":"Gossai","year":"2016","journal-title":"Am J Epidemiol."},{"issue":"7","key":"key\n\t\t\t\t2019021509101350800_djy084-B31","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/aje\/kwv281","article-title":"The natural history of human polyomaviruses and herpesviruses in early life\u2014the Rhea Birth Cohort in Greece","volume":"183","author":"Karachaliou","year":"2016","journal-title":"Am J Epidemiol."},{"key":"key\n\t\t\t\t2019021509101350800_djy084-B32","volume-title":"Manual of Clinical Virology","author":"Wiedbrauk","year":"1993"},{"issue":"4","key":"key\n\t\t\t\t2019021509101350800_djy084-B33","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1128\/IAI.69.4.2442-2447.2001","article-title":"Persistent Chlamydia trachomatis infections resist apoptotic stimuli","volume":"69","author":"Dean","year":"2001","journal-title":"Infect Immun."},{"issue":"1","key":"key\n\t\t\t\t2019021509101350800_djy084-B34","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0015-0282(16)49946-2","article-title":"Serologic evidence of prior chlamydial infection in patients with tubal ectopic pregnancy and contralateral tubal disease","volume":"47","author":"Hartford","year":"1987","journal-title":"Fertil Steril."},{"issue":"2","key":"key\n\t\t\t\t2019021509101350800_djy084-B35","first-page":"117","article-title":"Could epithelial ovarian cancer be associated with chlamydial infection?","volume":"28","author":"Wong","year":"2007","journal-title":"Eur J Gynaecol Oncol."},{"issue":"1","key":"key\n\t\t\t\t2019021509101350800_djy084-B36","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2009.07.042","article-title":"Chlamydia trachomatis, Mycoplasma genitalium, Neisseria gonorrhoeae, human papillomavirus, and polyomavirus are not detectable in human tissue with epithelial ovarian cancer, borderline tumor, or benign conditions","volume":"202","author":"Idahl","year":"2010","journal-title":"Am J Obstet Gynecol."},{"issue":"2","key":"key\n\t\t\t\t2019021509101350800_djy084-B37","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1006\/gyno.1996.0316","article-title":"Prevalence of mycoplasma conserved DNA in malignant ovarian cancer detected using sensitive PCR-ELISA","volume":"63","author":"Chan","year":"1996","journal-title":"Gynecol Oncol."},{"issue":"4","key":"key\n\t\t\t\t2019021509101350800_djy084-B38","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1023\/A:1011236803257","article-title":"Prospective study of antibody to human papilloma virus type 16 and risk of cervical, endometrial, and ovarian cancers (United States)","volume":"12","author":"Hisada","year":"2001","journal-title":"Cancer Causes Control."},{"issue":"6","key":"key\n\t\t\t\t2019021509101350800_djy084-B39","first-page":"642","article-title":"HPV and p53 expression in epithelial ovarian carcinoma","volume":"26","author":"Kuscu","year":"2005","journal-title":"Eur J Gynaecol Oncol."},{"issue":"9","key":"key\n\t\t\t\t2019021509101350800_djy084-B40","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1007\/s10096-012-1570-5","article-title":"Viral and bacterial aetiologies of epithelial ovarian cancer","volume":"31","author":"Shanmughapriya","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis."},{"issue":"4","key":"key\n\t\t\t\t2019021509101350800_djy084-B41","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/sj.bjc.6601172","article-title":"Detection of human papillomavirus-16 in ovarian malignancy","volume":"89","author":"Wu","year":"2003","journal-title":"Br J Cancer."},{"issue":"1","key":"key\n\t\t\t\t2019021509101350800_djy084-B42","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/pgp.0b013e318074b83f","article-title":"No metastatic cervical adenocarcinomas in a series of p16INK4a-positive mucinous or endometrioid advanced ovarian carcinomas: An analysis of the AGO Ovarian Cancer Study Group","volume":"27","author":"Wentzensen","year":"2008","journal-title":"Int J Gynecol Pathol."},{"issue":"16","key":"key\n\t\t\t\t2019021509101350800_djy084-B43","doi-asserted-by":"crossref","first-page":"8916","DOI":"10.1128\/JVI.00340-13","article-title":"Landscape of DNA virus associations across human malignant cancers: Analysis of 3,775 cases using RNA-Seq","volume":"87","author":"Khoury","year":"2013","journal-title":"J Virol."},{"issue":"9","key":"key\n\t\t\t\t2019021509101350800_djy084-B44","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1073\/pnas.90.9.3998","article-title":"Morphologic and antigenic characterization of interferon gamma-mediated persistent Chlamydia trachomatis infection in vitro","volume":"90","author":"Beatty","year":"1993","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"1","key":"key\n\t\t\t\t2019021509101350800_djy084-B45","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s00018-004-4367-6","article-title":"Is chlamydial heat shock protein 60 a risk factor for oncogenesis?","volume":"62","author":"Di Felice","year":"2005","journal-title":"Cell Mol Life Sci."},{"issue":"21","key":"key\n\t\t\t\t2019021509101350800_djy084-B46","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1056\/NEJMra1411426","article-title":"Pelvic inflammatory disease","volume":"372","author":"Brunham","year":"2015","journal-title":"N Engl J Med."}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jnci\/article-pdf\/111\/2\/129\/27786025\/djy084.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T09:26:43Z","timestamp":1550222803000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article\/111\/2\/129\/5001107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,21]]},"references-count":46,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,5,21]]},"published-print":{"date-parts":[[2019,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djy084","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"value":"0027-8874","type":"print"},{"value":"1460-2105","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,2]]},"published":{"date-parts":[[2018,5,21]]}}}